Pulmonary Fibrosis Week

HomePatientsLung Disease Week at the ATS2018Pulmonary Fibrosis Week ▶ Information for Experts
Information for Experts

pf

 

Pulmonary Fibrosis Foundation Products

The Pulmonary Fibrosis Foundation’s (PFF) Patient Communication Center is a hub for information and resources for patients, families, and healthcare professionals. Call 844.TalkPFF (844.825.5733) or email pcc@pulmonaryfibrosis.org. We will ship our educational materials free of charge.

PFF Patient Registry
The PFF Patient Registry is a resource of data gathered from 2,000 patient volunteers across the country to help researchers further understand the disease and develop treatments.

PFF Care Center Network
The PFF’s Care Center Network is comprised of 60 medical centers nationwide offering comprehensive and individualized care to those living with PF.

PFF Research Funds
These funds support both junior and established investigator research projects.

CME/CE Library
Explore CME/CE activities relating to education about pulmonary fibrosis and ILD.

 

ATS Educational Products

IDIOPATHIC PULMONARY FIBROSIS: CONTROVERSIES IN MANAGEMENT - PRO/CON DEBATE 
ATS MYTHBUSTERS: ONE OME TO RULE THEM ALL: WE WILL FIND A COMMON PRIME MOVER FOR PULMONARY FIBROSIS
ATS MYTHBUSTER: REVERSING FIBROSIS IN THE LUNGS IS BIOLOGICAL MISSION (IM)POSSIBLE 
IDIOPATHIC PULMONARY FIBROSIS: PAST, PRESENT, FUTURE
SCAR-CINOMAS: THE SHARED BIOLOGY AND CLINICAL OVERLAP OF FIBROSIS AND CANCER

 


 

ClinicianATS Journals on Pulmonary Fibrosis

 

American Journal of Respiratory and Critical Care Medicine

High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults
Link to Abstract
2017

Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections
Link to Abstract
2017

The Plasma Concentration of MUC5B is Associated with Clinical Outcomes in Paraquat Poisoned Patients
Link to Abstract
2017

An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis
Link to Abstract
2017

Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies
Link to Abstract
2016

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
Link to Abstract
2016

Accuracy and Reliability of Internet Resources for Information on Idiopathic Pulmonary Fibrosis
Link to Abstract
2016

Stretch-induced Activation of Transforming Growth Factor-β1 in Pulmonary Fibrosis
Link to Abstract
2016

Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities
Link to Abstract
2016

An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research
Link to Abstract
2016

 

 

American Journal of Respiratory Cell and Molecular Biology

PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice
Link to Abstract
2017

The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis
Link to Abstract
2017

MicroRNA-29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis
Link to Abstract
2017

Interplay Between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis
Link to Abstract
2017

Targeting HIF-1α/PDK1 Axis by Dichloroacetate (DCA) Suppresses Bleomycin-induced Pulmonary Fibrosis
Link to Abstract
2017

Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148
Link to Abstract
2017

SIRT1 Protects Against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Pro-inflammatory and Pro-fibrotic Processes
Link to Abstract
2017

Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis
Link to Abstract
2016

Role of Twist1 Phosphorylation in Angiogenesis and Pulmonary Fibrosis
Link to Abstract
2016

Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation
Link to Abstract
2016

Cu,Zn–Superoxide Dismutase–Mediated Redox Regulation of Jumonji Domain Containing 3 Modulates Macrophage Polarization and Pulmonary Fibrosis
Link to Abstract
2016

Matrix Remodeling in Pulmonary Fibrosis and Emphysema
Link to Abstract
2016

Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis
Link to Abstract
2016

Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease
Link to Abstract
2016

Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation
Link to Abstract
2016

 

 

Annals of ATS

Mitochondrial Dysfunction in Pulmonary Fibrosis
Link to Abstract
2017

Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science
Link to Abstract
2017

Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Link to Abstract
2017

Treatment of Systemic Sclerosis–related Interstitial Lung Disease: A Review of Existing and Emerging Therapies
Link to Abstract
2016

Pulmonary Fibrosis in Hermansky–Pudlak Syndrome
Link to Abstract
2016

 


 

ClinicianATS Statements, Guidelines and Reports

 

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research